During cancer treatment, which factors should be monitored by the exercise professional?

• A. Fatigue, neutropenia, anaemia, and infection risk.
• B. Body weight, blood pressure, cholesterol levels.
• C. Hair loss and skin changes.
• D. Respiratory rate alone.

Answer: (A)

During cancer treatment, exercise professionals should monitor fatigue, neutropenia, anaemia, and infection risk because these factors directly influence safety and how you can exercise. Fatigue indicates energy availability and helps tailor session duration and intensity so you don’t overexert yourself. Neutropenia lowers white blood cell counts, increasing susceptibility to infections, so monitoring guides when to delay sessions, adjust precautions, and coordinate with the medical team. Anaemia reduces the blood’s ability to carry oxygen, making it easier to become short of breath or dizzy; tracking it helps decide appropriate exercise intensity and pacing. Infection risk is a ongoing concern with treatments that affect the immune system, so recognizing symptoms and following medical clearance guidelines is essential before continuing or starting activity.

Other factors like body weight, blood pressure, and cholesterol can inform overall health, but they don’t directly address the immediate safety and functional response to exercise during active treatment. Hair loss or skin changes are cosmetic, and monitoring respiratory rate alone doesn’t provide the full picture of infection risk or blood health needed to guide safe exercise.